Myosteatosis As a Predictor of Toxicity Among Older Adults with DLBCL Receiving CHOP-Based Regimens

被引：0
|
作者：
Ye, Star [1 ]
Harmon, Christian [2 ]
Anabtawi, Nadia [3 ]
Ubersax, Clare [2 ]
Tucker, Abigail [2 ]
Goyal, Gaurav [1 ]
Shea, Lauren [1 ]
Narkhede, Mayur [1 ]
Mehta, Amitkumar [1 ]
Singh, Purnima [2 ]
Williams, Grant [1 ]
Bhatia, Smita [2 ]
Giri, Smith [2 ]
机构：
[1] Univ Alabama Birmingham, Dept Med, Div Hematol Oncol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Inst Canc Outcomes & Survivorship, Birmingham, AL USA
[3] Univ Alabama Birmingham, Heersink Sch Med, Birmingham, AL USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-163653
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3779 / 3780
页数：2
相关论文
共 50 条
  • [1] Multiple clonal MLL fusions in a patient receiving CHOP-based chemotherapy
    Shih, Shyh-Jen
    Fass, Joseph
    Buffalo, Vincent
    Lin, Dawei
    Singh, Sheetal P.
    Diaz, Manuel O.
    Vaughan, Andrew T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (01) : 50 - 57
  • [2] The influence of sarcopenia and myosteatosis on severe laboratory toxicity and overall mortality in older adults with cancer receiving chemotherapy
    Papadopoulos, Efthymios
    Wong, Andy Kin On
    Law, Sharon Hiu Ching
    Costa, Sarah
    Cheung, Angela
    Rozenberg, Dmitry
    Alibhai, Shabbir M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Immune reconstitution of B-cell lymphoma patients receiving CHOP-based chemotherapy containing rituximab
    Kurokawa, Toshiro
    Hase, Makiko
    Tokuman, Naoko
    Yoshida, Takashi
    HEMATOLOGICAL ONCOLOGY, 2011, 29 (01) : 5 - 9
  • [4] Time spent at home among older adults with acute myeloid leukemia receiving azacitidine- or venetoclax-based regimens
    Jensen, Christopher E.
    Heiling, Hilary M.
    Beke, Konan E.
    Deal, Allison M.
    Bryant, Ashley L.
    Coombs, Lorinda A.
    Foster, Matthew C.
    Richardson, Daniel R.
    HAEMATOLOGICA, 2023, 108 (04) : 1006 - 1014
  • [5] Severe neutropenia and relative dose intensity among patients <65 and ≥65 years with non-Hodgkin’s lymphoma receiving CHOP-based chemotherapy
    Lee S. Schwartzberg
    Mansoor Saleh
    Sadie Whittaker
    Esteban Abella
    Supportive Care in Cancer, 2014, 22 : 1833 - 1841
  • [6] Optimizing Medication Regimens for Older Adults Receiving Home Care Service
    Chen, Liang-Kung
    AGING MEDICINE AND HEALTHCARE, 2024, 15 (02): : 44 - 46
  • [7] Clinical characteristics and survival analysis of LBL patients treated with CHOP-based regimens alone or with consolidation high dose treatment and HSCT
    Shi, Y. K.
    Qin, Y.
    He, X. H.
    Han, X. H.
    Zhou, S. Y.
    Yang, J. L.
    Yang, S.
    Zhang, C. G.
    Wang, Q. L.
    Feng, F. Y.
    Sun, Y.
    ANNALS OF ONCOLOGY, 2008, 19 : 221 - 221
  • [8] A prospective study to determine survival outcome to CHOP-based therapy in patients with double expresser DLBCL: Single centre experience from India
    Asati, V.
    Lakshmaiah, K. C.
    Babu, K. Govind
    Lokanath, D.
    Jacob, L. A.
    Babu, M. C. Suresh
    Lokesh, K. N.
    Rajeev, L. K.
    Rudresha, A. H.
    Smitha, S. C.
    Giri, G. V.
    Koppaka, D.
    Anand, A.
    Chethan, R.
    Chaudhuri, T.
    Patidar, R.
    Goyal, A.
    Premalata, C. S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] Retrospective Analysis of Relative Dose Intensity in Patients With Non-Hodgkin Lymphoma Receiving CHOP-based Chemotherapy and Pegfilgrastim
    Balducci, Lodovico
    Mo, May
    Abella, Esteban
    Saven, Alan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2014, 37 (06): : 603 - 610
  • [10] Predictors of Toxicity Among Older Adults with Cancer
    Extermann, Martine
    Chetty, Indrin J.
    Brown, Stephen L.
    Al-Jumayli, Mohammed
    Movsas, Benjamin
    SEMINARS IN RADIATION ONCOLOGY, 2022, 32 (02) : 179 - 185
12345